Allworth Financial’s Rani Therapeutics RANI Stock Holding History
Bought
Maintained
Sold
Other funds holding RANI
AIC
SL
Allworth Financial's RANI Position: Q3 2026 in Review
Allworth Financial sold out of Rani Therapeutics (RANI) in Q3 2026, closing a stake of 3,119 shares — an estimated $2.37K sold.
Allworth Financial first reported a position in RANI in Q4 2022 and held it in 15 quarters. The position peaked at $18.4K in Q4 2022. 68 funds tracked by Wall St. Rank hold RANI as of Q3 2026.
- Allworth Financial reported no remaining Rani Therapeutics position as of Q3 2026 after selling out during the quarter.
- Allworth Financial sold 3,119 Rani Therapeutics shares in Q3 2026, an estimated $2.37K.
- Allworth Financial first reported a position in Rani Therapeutics in Q4 2022 and held it in 15 quarters.
- Allworth Financial's Rani Therapeutics position peaked at $18.4K in Q4 2022.
- 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2026.
Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.